These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


515 related items for PubMed ID: 21116052

  • 1. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
    Lilja AM, Porras O, Storelli E, Nordberg A, Marutle A.
    J Alzheimers Dis; 2011; 23(2):335-47. PubMed ID: 21116052
    [Abstract] [Full Text] [Related]

  • 2. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
    Ni R, Marutle A, Nordberg A.
    J Alzheimers Dis; 2013; 33(3):841-51. PubMed ID: 23042213
    [Abstract] [Full Text] [Related]

  • 3. The consequences of reducing expression of the alpha7 nicotinic receptor by RNA interference and of stimulating its activity with an alpha7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease.
    Qi XL, Nordberg A, Xiu J, Guan ZZ.
    Neurochem Int; 2007; 51(6-7):377-83. PubMed ID: 17493709
    [Abstract] [Full Text] [Related]

  • 4. Beta-amyloid peptide activates non-alpha7 nicotinic acetylcholine receptors in rat basal forebrain neurons.
    Fu W, Jhamandas JH.
    J Neurophysiol; 2003 Nov; 90(5):3130-6. PubMed ID: 12890800
    [Abstract] [Full Text] [Related]

  • 5. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro.
    Mousavi M, Hellström-Lindahl E.
    Neurochem Int; 2009 Nov; 54(3-4):237-44. PubMed ID: 19111588
    [Abstract] [Full Text] [Related]

  • 6. beta-Amyloid activates presynaptic alpha7 nicotinic acetylcholine receptors reconstituted into a model nerve cell system: involvement of lipid rafts.
    Khan GM, Tong M, Jhun M, Arora K, Nichols RA.
    Eur J Neurosci; 2010 Mar; 31(5):788-96. PubMed ID: 20374280
    [Abstract] [Full Text] [Related]

  • 7. Selective coactivation of α7- and α4β2-nicotinic acetylcholine receptors reverses beta-amyloid-induced synaptic dysfunction.
    Roberts JP, Stokoe SA, Sathler MF, Nichols RA, Kim S.
    J Biol Chem; 2021 Mar; 296():100402. PubMed ID: 33571523
    [Abstract] [Full Text] [Related]

  • 8. Expression of nicotinic receptors on primary cultures of rat astrocytes and up-regulation of the alpha7, alpha4 and beta2 subunits in response to nanomolar concentrations of the beta-amyloid peptide(1-42).
    Xiu J, Nordberg A, Zhang JT, Guan ZZ.
    Neurochem Int; 2005 Sep; 47(4):281-90. PubMed ID: 15955596
    [Abstract] [Full Text] [Related]

  • 9. Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease.
    Parri HR, Hernandez CM, Dineley KT.
    Biochem Pharmacol; 2011 Oct 15; 82(8):931-42. PubMed ID: 21763291
    [Abstract] [Full Text] [Related]

  • 10. JN403, in vitro characterization of a novel nicotinic acetylcholine receptor alpha7 selective agonist.
    Feuerbach D, Nozulak J, Lingenhoehl K, McAllister K, Hoyer D.
    Neurosci Lett; 2007 Apr 06; 416(1):61-5. PubMed ID: 17314009
    [Abstract] [Full Text] [Related]

  • 11. A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity.
    Liu Q, Xie X, Emadi S, Sierks MR, Wu J.
    Neuropharmacology; 2015 Oct 06; 97():457-63. PubMed ID: 25959067
    [Abstract] [Full Text] [Related]

  • 12. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques.
    Yu WF, Guan ZZ, Bogdanovic N, Nordberg A.
    Exp Neurol; 2005 Mar 06; 192(1):215-25. PubMed ID: 15698636
    [Abstract] [Full Text] [Related]

  • 13. Statins prevent beta-amyloid inhibition of sympathetic alpha7-nAChR-mediated nitrergic neurogenic dilation in porcine basilar arteries.
    Si ML, Long C, Yang DI, Chen MF, Lee TJ.
    J Cereb Blood Flow Metab; 2005 Dec 06; 25(12):1573-85. PubMed ID: 16192990
    [Abstract] [Full Text] [Related]

  • 14. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
    Malysz J, Anderson DJ, Grønlien JH, Ji J, Bunnelle WH, Håkerud M, Thorin-Hagene K, Ween H, Helfrich R, Hu M, Gubbins E, Gopalakrishnan S, Puttfarcken PS, Briggs CA, Li J, Meyer MD, Dyhring T, Ahring PK, Nielsen EØ, Peters D, Timmermann DB, Gopalakrishnan M.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):863-74. PubMed ID: 20504915
    [Abstract] [Full Text] [Related]

  • 15. A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides.
    Liu Q, Huang Y, Xue F, Simard A, DeChon J, Li G, Zhang J, Lucero L, Wang M, Sierks M, Hu G, Chang Y, Lukas RJ, Wu J.
    J Neurosci; 2009 Jan 28; 29(4):918-29. PubMed ID: 19176801
    [Abstract] [Full Text] [Related]

  • 16. Oligomeric aggregates of amyloid beta peptide 1-42 activate ERK/MAPK in SH-SY5Y cells via the alpha7 nicotinic receptor.
    Young KF, Pasternak SH, Rylett RJ.
    Neurochem Int; 2009 Dec 28; 55(8):796-801. PubMed ID: 19666073
    [Abstract] [Full Text] [Related]

  • 17. Alpha7 nAChR-mediated activation of MAP kinase pathways in PC12 cells.
    Gubbins EJ, Gopalakrishnan M, Li J.
    Brain Res; 2010 Apr 30; 1328():1-11. PubMed ID: 20211606
    [Abstract] [Full Text] [Related]

  • 18. In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease.
    Bitner RS, Bunnelle WH, Decker MW, Drescher KU, Kohlhaas KL, Markosyan S, Marsh KC, Nikkel AL, Browman K, Radek R, Anderson DJ, Buccafusco J, Gopalakrishnan M.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):875-86. PubMed ID: 20504913
    [Abstract] [Full Text] [Related]

  • 19. Requirement of α7 nicotinic acetylcholine receptors for amyloid β protein-induced depression of hippocampal long-term potentiation in CA1 region of rats in vivo.
    Li SF, Wu MN, Wang XH, Yuan L, Yang D, Qi JS.
    Synapse; 2011 Nov 01; 65(11):1136-43. PubMed ID: 21584864
    [Abstract] [Full Text] [Related]

  • 20. Neuronal nicotinic acetylcholine receptors serve as sensitive targets that mediate beta-amyloid neurotoxicity.
    Liu Q, Wu J.
    Acta Pharmacol Sin; 2006 Oct 01; 27(10):1277-86. PubMed ID: 17007734
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.